Medgend Icon







discontinued


Arnuity Ellipta FDA Approved Drugs

ARNUITY ELLIPTA [Fluticasone FuroateC27H29F3O6S]
RX
-
0.1mg/inh (inhalation powder)
0.2mg/inh (inhalation powder)
GlaxosmithklineAug 20, 2014
  • Indicated for the once-daily maintenance treatment of asthma as prophylactic therapy in patients aged 12 years of age and older.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

FLONASE SENSIMIST ALLERGY RELIEF [Fluticasone FuroateC27H29F3O6S]
OTC
-
0.0275mg/spray (nasal spray, metered)
Glaxosmithkline ConsAug 2, 2016
  • Otc use: allergy symptom reliever; temporarily relieves these symptoms due to hay fever or other upper respiratory allergies; nasal congestion, runny nose, sneezing, itchy nose, and (itchy water eyes (ages 12 and up)).
  • The treatment of the symptoms of seasonal and perennial allergic rhinitis in patients 2 years of age and older.
  • Treatment of rhinitis comprising the nasal application of a pharmaceutical formulation as claimed in us patent 7541350.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.